RVL Pharmaceuticals plc Accrued Liabilities, Current
RVL Pharmaceuticals plc had Accrued Liabilities, Current of $7.86 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-08-14
- 2023-06-30: Accrued Liabilities, Current $7.86M.
- 2023-03-31: Accrued Liabilities, Current $9.27M.
- 2022-12-31: Accrued Liabilities, Current $15.39M.
- 2022-09-30: Accrued Liabilities, Current $13.95M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $7.86M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $9.27M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $15.39M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $13.95M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $11.95M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $14.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $13.08M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $18.52M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $13.42M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $42.72M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $16.95M 10-K · filed 2022-03-30 | $47.52M 10-K · filed 2021-03-30 |
| 2020-09-30 | $45.38M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $48.35M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $47.26M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $17.64M 8-K · filed 2021-09-08 | $65.25M 10-K · filed 2020-03-19 |
| 2019-09-30 | $66.08M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $75.52M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $72.48M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $87.24M 10-K · filed 2020-03-19 | $87.24M 10-K · filed 2019-03-28 |
| 2018-09-30 | $81.58M 10-Q · filed 2018-11-08 | |
| 2017-12-31 | $81.93M 8-K · filed 2019-12-20 |